Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Sanovas Inc.
SAUSALITO, Calif., April 28, 2014 /PRNewswire/ -- Sanovas Inc. (www.sanovas.com), a Life Sciences Accelerator developing and commercializing next-generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that it has appointed five experienced executives to its management team: Ray Gamini (Sun Microsystems, Cisco Systems), Vice President of Finance; Roy Morgan (Abbott Laboratories, NIPRO Diabetes Systems, Stryker), Director, Research & Development; Christian Haller (MPR Associates), Vice President, Business Development; Steve Budill (Merit Medical, Stryker), Vice President, Product Management; and, John Galasso (Abbott Laboratories, Ascend/Lucent Technologies), Manager, Mechanical Engineering.
"This is a very exciting time for Sanovas," said Larry Gerrans, Co-Founder, President and CEO. "The addition of these proven professionals is consistent with Sanovas' aspiration to surround its excellence with the very best minds and the very best talents. We are creating and commercializing potentially blockbuster technologies in areas of the human body that have been inaccessible ... until now.
"Roy, Christian, Ray, Steve, and John have amassed unique skills and a demonstrated track record of success in the Life Sciences and for Fortune 500 companies. Their experience and skill sets across a wide variety of management functions, including executive management, finance, operations, engineering, manufacturing, clinical affairs and sales bring integral capacities that will strengthen Sanovas' capacity for aggressive growth," added Gerrans.
At the heart of the Sanovas companies' scientific advances is the miniaturization of tools for minimally invasive surgery, or "M-I-S." Its products extend access beyond current limits, enabling physicians to diagnose and perform therapeutic interventions in spaces as small as one millimeter in diameter that have previously been unreachable. Sanovas expects to commercialize the technology in coordination with its various partners to address unmet clinical needs in Oncology, Pulmonology, Cardiology, ENT, GI, General Surgery, Neurosurgery, Urology and Gynecology.
Read more news from Sanovas.
©2012 PR Newswire. All Rights Reserved.